Prognostic significance of tumor doubling time in evaluating operability in pulmonary metastatic disease.
D000230:Adenocarcinoma / Q000601:surgery; D000293:Adolescent; D000328:Adult; D000368:Aged; D001132:Arm; D001859:Bone Neoplasms / Q000601:surgery; D001943:Breast Neoplasms / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000601:surgery; D002648:Child; D005260:Female; D005354:Fibrosarcoma / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D007822:Laryngeal Neoplasms / Q000601:surgery; D007866:Leg; D008080:Liposarcoma / Q000601:surgery; D008175:Lung Neoplasms / Q000601:surgery*; D008297:Male; D008441:Maxillary Neoplasms / Q000601:surgery; D008443:Maxillary Sinus / Q000601:surgery; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000601:surgery*; D012516:Osteosarcoma / Q000601:surgery; D011379:Prognosis; D013584:Sarcoma, Synovial / Q000601:surgery; D012811:Sigmoid Neoplasms / Q000601:surgery; D013964:Thyroid Neoplasms / Q000601:surgery